ADALIMUMAB-RYVK

Generic: ADALIMUMAB-RYVK

Quallent Pharmaceuticals Health LLCManufacturer
SUBCUTANEOUSRoute
2024-02-23Original Approval

ADALIMUMAB-RYVK is FDA application BLA761299, sponsored by ALVOTECH USA INC. Any recalls listed below come from FDA drug enforcement reports, and reaction counts are the number of FAERS adverse event reports that mention the drug and that reaction; a report does not prove the drug caused it.

Top Reported Reactions

1
DRUG INEFFECTIVE
10,683 reports
2
OFF LABEL USE
8,634 reports
3
RHEUMATOID ARTHRITIS
5,921 reports
4
FATIGUE
5,637 reports
5
PAIN
5,598 reports
6
ARTHRALGIA
5,337 reports
7
RASH
4,777 reports
8
CONDITION AGGRAVATED
4,674 reports
9
DRUG INTOLERANCE
4,347 reports
10
SYSTEMIC LUPUS ERYTHEMATOSUS
4,224 reports